The DOI matches its Crossref record; 282 of the 286 references it cites were found in a registry or an index.
Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Abstract
Sarcopenic obesity (SO) is a condition characterized by the occurrence of both sarcopenia and obesity and imposes a heavy burden on the health of the elderly. Controversies and challenges regarding the definition, diagnosis and treatment of SO still remain because of its complex pathogenesis and limitations. Over the past few decades, numerous studies have revealed that myokines secreted from skeletal muscle play significant roles in the regulation of muscle mass and function as well as metabolic homeostasis. Abnormalities in myokines may trigger and promote the pathogenesis underlying age-related and metabolic diseases, including obesity, sarcopenia, type 2 diabetes (T2D), and SO. This review mainly focuses on the role of myokines as potential biomarkers for the early diagnosis and therapeutic targets in SO.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hormones were identified and subsequently leveraged for use as therapeutics throughout the 20th century but it is only in more recent times that numerous families of secreted signaling molecules bearing the suffix “‐kines” such as myokines, 243 osteokines, adipokines, 244 and hepatokines 245 have been identified. 242”
From The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments (2022) · cites this paper as [243]
Citations
Cites
1 retracted
Items 201–282 of 282
Myonectin deletion promotes adipose fat storage and reduces liver steatosis
Little, H. C., Rodriguez, S., Lei, X., Tan, S. Y., Stewart, A. N., Sahagun, A., Sarver, D. C., & William Wong, G. (2019) · The FASEB Journal · doi:10.1096/fj.201900520r · Cited by 78
Age‐Related Modifications in Circulating IL‐15 Levels in Humans
Gangemi, S., Basile, G., Monti, D., Merendino, R. A., Pasquale, G. D., Bisignano, U., Nicita-Mauro, V., & Franceschi, C. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.245 · Cited by 77
Bae, J. Y. (2018) · BioMed Research International · doi:10.1155/2018/6283932 · Cited by 77
Navarro, A. (2001) · Frontiers in bioscience · doi:10.2741/navarro · Cited by 75
Are declining testosterone levels a major risk factor for ill-health in aging men?
Yeap, B. B. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.60 · Cited by 75
Myonectin Predicts the Development of Type 2 Diabetes
Li, K., Liao, X., Wang, K., Mi, Q., Zhang, T., Jia, Y., Xu, X., Luo, X., Zhang, C., Liu, H., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01604 · Cited by 73
Self-citationMeador, B. M., Krzyszton, C. P., Johnson, R. W., & Huey, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01079.2007 · Cited by 72
Decorin is a secreted protein associated with obesity and type 2 diabetes
Bolton, K. A., Segal, D., McMillan, J. S., Jowett, J. B. M., Heilbronn, L. K., Abberton, K. M., Zimmet, P., Chisholm, D. J., Collier, G. R., & Walder, K. R. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.41 · Cited by 71
Short, K. R., Chadwick, J. Q., Teague, A. M., Tullier, M. A., WOLBERT, L. D., COLEMAN, C. L., & Copeland, K. C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02698 · Cited by 71
Babaknejad, N., Nayeri, H., Hemmati, R., Bahrami, S., & Esmaillzadeh, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0623-2909 · Cited by 70
Metabolic Health—The Role of Adipo-Myokines
Gräf, C., & Ferrari, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246159 · Cited by 70
Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2
Lieu, S., Hansen, E., Dedini, R. D., Behonick, D. J., Werb, Z., Miclau, T., Marcucio, R., & Colnot, C. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.006304 · Cited by 69
Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines
Seldin, M. M., & Wong, G. W. (2012) · Adipocyte · doi:10.4161/adip.20877 · Cited by 69
Quinn, L. S., Anderson, B. G., Strait‐Bodey, L., & Wolden‐Hanson, T. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.012 · Cited by 68
Dağdeviren, S., Jung, D. Y., Lee, E., Friedline, R. H., Noh, H. L., Kim, J. H., Patel, P. R., Tsitsilianos, N., Tsitsilianos, A. V., Tran, D. A., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00181-16 · Cited by 68
Re Cecconi, A. D., Forti, M., Chiappa, M., Zhu, Z., Zingman, L. V., Cervo, L., Beltrame, L., Marchini, S., & Piccirillo, R. (2019) · Cancers · doi:10.3390/cancers11101541 · Cited by 66
Jia, D., Cai, M., Xi, Y., Du, S., & Tian, Z. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.12.009 · Cited by 65
Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity
Argilés, J. M. A., López-Soriano, F. J., & Busquets, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.010 · Cited by 64
The relationship between plasma interleukin-15 levels and sarcopenia in outpatient older people
Yalçın, A., Sılay, K., Balik, A. R., Avcıoğlu, G., & Şenat, A. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0848-y · Cited by 64
Pérez-Sotelo, D., Roca-Rivada, A., de la Torre, I. B., Baltar, J., Castro, A. I., Domínguez, E., Collado, M., Casanueva, F. F., & Pardo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16602-z · Cited by 59
Insulin resistance and mitochondrial function in skeletal muscle
Dela, F., & Helge, J. W. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.019 · Cited by 57
Inhibition of the myostatin/Smad signaling pathway by short decorin-derived peptides
Shafey, N. E., Guesnon, M., Simon, F., Deprez, E., Cosette, J., Stockholm, D., Scherman, D., Bigey, P., & Kichler, A. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.019 · Cited by 57
Ghanemi, A., Melouane, A., Yoshioka, M., & St‐Amand, J. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105627 · Cited by 57
Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects
Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Lenzi, A., & Donini, L. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145811 · Cited by 56
Liu, X., Wang, Y., Hou, L., Xiong, Y., & Zhao, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25735 · Cited by 56
Colombo, E., Bedogni, F., Lorenzetti, I., Landsberger, N., Previtali, S. C., & Farina, C. (2013) · The Journal of Pathology · doi:10.1002/path.4228 · Cited by 54
Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus
Wu, D., Li, L., Yang, M., Liu, H., & Yang, G. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0131 · Cited by 51
Sabaratnam, R., Pedersen, A. J. T., Kristensen, J. M., Handberg, A., Wojtaszewski, J. F. P., & Højlund, K. (2018) · Physiological Reports · doi:10.14814/phy2.13723 · Cited by 50
Regenerative Medicine Approaches for Age-Related Muscle Loss and Sarcopenia: A Mini-Review
Naranjo, J. D., Dziki, J. L., & Badylak, S. F. (2017) · Gerontology · doi:10.1159/000479278 · Cited by 49
Du, Y., Ye, X., Lu, A., Zhao, D., Liu, J., Cheng, J., & Yang, T. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108068 · Cited by 49
Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration
Rebalka, I. A., Monaco, C. M. F., Varah, N. E., Berger, T., D’Souza, D. M., Zhou, S., Mak, T. W., & Hawke, T. J. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00195.2017 · Cited by 48
Insulin‐Like Growth Factor I Regulation and Its Actions in Skeletal Muscle
Vassilakos, G., & Barton, E. R. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180010 · Cited by 48
Quinn, L., Anderson, Conner, Pistilli, & Wolden-Hanson (2011) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s19007 · Cited by 47
The Splicing of the IGF-I Gene to Yield Different Muscle Growth Factors
Goldspink, G., & Yang, S. Y. (2004) · Advances in genetics · doi:10.1016/s0065-2660(04)52002-3 · Cited by 46
Irisin treatment improves healing of dystrophic skeletal muscle
Reza, M. M., Sim, C. M., Subramaniyam, N., Ge, X., Sharma, M., Kambadur, R., & McFarlane, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21636 · Cited by 45
Nakamura, S. K., Nakano, S., Miyoshi, T., Yamanouchi, K., Matsuwaki, T., & Nishihara, M. (2012) · Aging · doi:10.18632/aging.100426 · Cited by 44
Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes
Broskey, N. T., Obanda, D. N., Burton, J. H., Cefalu, W. T., & Ravussin, É. (2018) · Metabolism · doi:10.1016/j.metabol.2017.12.012 · Cited by 44
Bhatt, S. P., Nigam, P., Misra, A., Guleria, R., Luthra, K., Jain, S. K., & Pasha, M. A. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040977 · Cited by 43
Broholm, C., Brandt, C., Schultz, N. S., Nielsen, A. R., Pedersen, B. K., & Schéele, C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00586.2011 · Cited by 43
A Role for SPARC in the Moderation of Human Insulin Secretion
Harries, L. W., McCulloch, L. J., Holley, J. E., Rawling, T. J., Welters, H. J., & Kos, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068253 · Cited by 42
Levy, Y. A., Ciaraldi, T. P., Mudaliar, S. R. D., Phillips, S. A., & Henry, R. R. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00513.2014 · Cited by 42
Toloza, F. J. K., Mantilla-Rivas, J. O., Pérez-Matos, M. C., Ricardo-Silgado, M. L., Morales-Alvarez, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Arévalo-Garcia, M. L., Tolosa-González, G., & Mendivil, C. O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00005 · Cited by 42
Nascimento, D. D. C., Oliveira, S. D. C., Vieira, D. C. L., Funghetto, S. S., Silva, A. D. O., Valduga, R., Schoenfeld, B. J., & Prestes, J. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s187285 · Cited by 42
SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo
Jørgensen, L. H., Jepsen, P. L., Boysen, A., Dalgaard, L. B., Hvid, L. G., Ørtenblad, N., Ravn, D., Sellathurai, J., Møller‐Jensen, J., Lochmüller, H., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.013 · Cited by 41
SPARC is up-regulated during skeletal muscle regeneration and inhibits myoblast differentiation.
Petersson, S. J., Jørgensen, L. H., Andersen, D. C., Nørgaard, R. C., Jensen, C. H., & Schrøder, H. D. (2013) · PubMed · doi:10.14670/hh-28.1451 · Cited by 40
MG53: Biological Function and Potential as a Therapeutic Target
Zhang, Y., Wu, H., Lv, F., & Xiao, R. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108241 · Cited by 40
Fujimoto, T., Sugimoto, K., Takahashi, T., Yasunobe, Y., Keyu, X., Tanaka, M., Ohnishi, Y., Yoshida, S., Kurinami, H., Akasaka, H., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.024 · Cited by 40
Increased circulating myostatin in patients with type 2 diabetes mellitus
Wang, F., Liao, Y., Li, X., Ren, C., Cheng, C., & Ren, Y. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0092-9 · Cited by 39
Adipokines in healthy skeletal muscle and metabolic disease
Coles, C. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27511-6_6 · Cited by 39
Nuclear matrix metalloproteinase-2 in the cardiomyocyte and the ischemic-reperfused heart
Baghirova, S., Hughes, B. G., Poirier, M., Kondo, M. Y., & Schulz, R. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.04.004 · Cited by 38
Son, J. S., Kim, H., Son, Y., Lee, H., Chae, S. A., Seong, J. K., & Song, W. J. (2017) · Muscle & Nerve · doi:10.1002/mus.25596 · Cited by 38
Rossi, F. E., Lira, F. S., Silva, B. S. D. A., Freire, A. P. C. F., Ramos, E. M. C., & Gobbo, L. A. (2018) · Aging Clinical and Experimental Research · doi:10.1007/s40520-018-1029-3 · Cited by 38
Brain derived neurotrophic factor in newly diagnosed diabetes and prediabetes
Liu, W., Han, X., Zhou, X., Zhang, S., Cai, X., Zhang, L., Li, Y., Li, M., Gong, S., & Ji, L. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.002 · Cited by 36
Chen, W.-J., Liu, Y., Sui, Y.-B., Yang, H., Chang, J.-R., Tang, C., Qi, Y., Zhang, J., & Yin, X. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0199-x · Cited by 36
Kim, C.-S., Joe, Y., Choi, H., Back, S. H., Park, J. W., Chung, H., Roh, E., Kim, M., Ha, T. Y., & Yu, R. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0221-3 · Cited by 36
Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle
Brandt, N., O’Neill, H. M., Kleinert, M., Schjerling, P., Vernet, E., Steinberg, G. R., Richter, E. A., & Jørgensen, S. B. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00313.2014 · Cited by 35
Absence of the proteoglycan decorin reduces glucose tolerance in overfed male mice
Svärd, J., Røst, T. H., Sommervoll, C. E. N., Haugen, C., Gudbrandsen, O. A., Mellgren, A. E. C., Rødahl, E., Fernø, J., Dankel, S. N., Sagen, J. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37501-x · Cited by 35
Intracellular MMP‐2 Activity in Skeletal Muscle Is Associated With Type II Fibers
Hadler‐Olsen, E., Solli, A. I., Hafstad, A. D., Winberg, J., & Uhlin‐Hansen, L. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24694 · Cited by 33
Evers-van Gogh, I. J. A., Oteng, A.-B., Alex, S., Hamers, N., Catoire, M., Stienstra, R., Kalkhoven, E., & Kersten, S. (2016) · Diabetologia · doi:10.1007/s00125-015-3822-2 · Cited by 33
Hangelbroek, R., Knuiman, P., Tieland, M., & de Groot, C. P. G. M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.02.008 · Cited by 32
Tanaka, M., Masuda, S., Yamakage, H., Inoue, T., Ohue‐Kitano, R., Yokota, S., Kusakabe, T., Wada, H., Sanada, K., Ishii, K., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.041 · Cited by 32
Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy
Welc, S. S., Flores, I., Wehling‐Henricks, M., Ramos, J. N., Wang, Y., Bertoni, C., & Tidball, J. G. (2019) · Nature Communications · doi:10.1038/s41467-019-10614-1 · Cited by 32
Hunt, L., & White, J. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-27511-6_3 · Cited by 31
Distribution and activation of matrix metalloproteinase-2 in skeletal muscle fibers
Ren, X., Lamb, G. D., & Murphy, R. M. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00113.2019 · Cited by 31
Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients
Chen, W.-J., Liu, Y., Sui, Y.-B., Zhang, B., Zhang, X., & Yin, X. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116675493 · Cited by 30
New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Catalina, M. O., Redondo, P. C., Granados, M. P., Cantonero, C., Sánchez-Collado, J., Albarrán, L., & López, J. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205162248 · Cited by 30
Dual function of MG53 in membrane repair and insulin signaling
Tan, T., Ko, Y., & Ma, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.8.079 · Cited by 28
Lee, H. J., Lee, J. O., Lee, Y. W., Kim, S. A., Park, S. H., & Kim, H. S. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.10.013 · Cited by 28
Bolton, K. A., Segal, & Walder (2012) · Biologics · doi:10.2147/btt.s27925 · Cited by 27
Role of Angptl4/Fiaf in exercise-induced skeletal muscle AMPK activation
Chang, H., Kwon, O., Shin, M.-S., Kang, G. M., Leem, Y. H., Lee, C. H., Kim, S. J., Roh, E., Kim, H.-K., Youn, B., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00984.2016 · Cited by 27
Insulin‐like growth factor‐I E peptides: implications for ageing skeletal muscle
Velloso, C. P., & Harridge, S. D. R. (2009) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.00997.x · Cited by 26
Nakamura, K., Yamanouchi, K., & Nishihara, M. (2013) · Aging Cell · doi:10.1111/acel.12168 · Cited by 26
Yang, H., Zhao, L., Zhang, J., Tang, C., Qi, Y., & Zhang, J. (2015) · International Journal of Sports Medicine · doi:10.1055/s-0034-1398653 · Cited by 22
Circulating myokine levels in different stages of glucose intolerance
Park, K., Ahn, C. W., Park, J. S., Kim, Y.-S., & Nam, J. S. (2020) · Medicine · doi:10.1097/md.0000000000019235 · Cited by 22
The manifold role of the mitochondria in skeletal muscle insulin resistance
Cade, W. T. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000480 · Cited by 21
ANGPTL4 — the link binding obesity and glucose intolerance
Morris, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.35 · Cited by 20
Gysel, T., Tonoli, C., Pardaens, S., Cambier, D. C., Kaufman, J.-M., Zmierczak, H.-G., Goemaere, S., Lapauw, B., & Calders, P. (2016) · Europe PMC (PubMed Central) · Cited by 18
Exercise-induced SPARC prevents tumorigenesis of colon cancer
Liu, Y., & Hsiao, M. (2012) · Gut · doi:10.1136/gutjnl-2012-303235 · Cited by 16
Son, J. S., Kim, J. H., Kim, H.-J., Yoon, D. H., Kim, J., Song, H. S., & Song, W. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24940 · Cited by 16
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge
Arrieta, H., Rodriguez‐Larrad, A., & Irazusta, J. (2019) · Gerontology · doi:10.1159/000496469 · Cited by 14
Myostatin: A Powerful Biomarker for Sarcopenia and Frailty?
Laurent, M. R., Dupont, J., Dejaeger, M., & Gielen, E. (2019) · Gerontology · doi:10.1159/000495839 · Cited by 12
Role of myokines in the maintenance of whole-body metabolic homeostasis.
Kostrominova, T. Y. (2016) · PubMed · Cited by 11
Flagged first, then by citations
4 of the 286 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Batsis, 2018, Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies, Nat. Rev. Endocrinol., 14, 513, 10.1038/s41574-018-0062-9 · DOI · Paper page
- Di Meo, 2017, Skeletal muscle insulin resistance: role of mitochondria and other ROS sources, J. Endocrinol., 233, R15, 10.1530/JOE-16-0598 · DOI · Paper page
- Kostrominova, 2016, Role of myokines in the maintenance of whole-body metabolic homeostasis, Minerva Endocrinol., 41, 403
- Lipina, 2017, Lipid modulation of skeletal muscle mass and function, J. Cachexia. Sarcopenia Muscle, 8, 190, 10.1002/jcsm.12144 · DOI · Paper page
Cited by
Sorted by citations
Bilski, J., Pierzchalski, P., Szczepanik, M., Bonior, J., & Zoladz, J. A. (2022) · Cells · doi:10.3390/cells11010160 · Cited by 269
“Disorders in myokine secretion may play a role in the pathogenesis of age-related and metabolic diseases, including obesity, T2D, sarcopenia, and SO [111,243,244].”
BackgroundLiu, C., Wong, P. Y., Chung, Y. L., Chow, S. K., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023) · Obesity Reviews · doi:10.1111/obr.13534 · Cited by 247
“The pathogenetic roles of these biomarkers in SO and SO-related diseases require further investigation to explore whether they are potential therapeutic targets.(131) Simi-”
BackgroundSkeletal muscle energy metabolism in obesity
Mengeste, A. M., Rustan, A. C., & Lund, J. (2021) · Obesity · doi:10.1002/oby.23227 · Cited by 141
“Moreover, it is quite likely that other myokines with therapeutic potential for treating obesity and associated metabolic abnormalities will be explored in the future (89).”
BackgroundExercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors
Alizadeh Pahlavani, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.811751 · Cited by 145
“Myokines act as a mediator between skeletal muscle and other tissues (13).”
BackgroundInfluentialSarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
Scisciola, L., Fontanella, R. A., Surina, S., Cataldo, V., Paolisso, G., & Barbieri, M. (2021) · Life · doi:10.3390/life11020173 · Cited by 153
“It was also demonstrated that LIF, via PKB/extracellular signal-regulated-mediated c-fos induction, protects against amyloid β-induced neurotoxicity [112].”
Background
Metadata
- Authors
- Guo, A., Li, K., & Xiao, Q.
- Affiliations
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Corresponding author
- Xiao, Qian
- Venue
- Experimental Gerontology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 139
- Pages
- 111022
- ISSN
- 0531-5565 (ISSN-L)
- OpenAlex
- W3043914821
- Cited by
- 83
- References
- 286
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 9 · 2023: 20 · 2022: 16 · 2021: 12 · 2020: 1
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chongqing Medical University
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- sarcopenic obesity, myokines, skeletal muscle, biomarkers, therapeutic target, sarcopenia, obesity, type 2 diabetes, aging, metabolic homeostasis, muscle mass and function
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Humans, Obesity, Biomarkers, Muscle, Skeletal, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review